Physician profile
Kissa Walker
NPI 1932725165
$535.44
in general payments reported to CMS, 2019-2025
8 companies · $309 in 2025
The $309 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $17.36 · 2022: $55.23 · 2024: $154 · 2025: $309.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $463.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $462.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $121.22 | 2024-2025 | Farxiga |
| Novo Nordisk INC | $77.82 | 2022-2025 | Ozempic, Rybelsus |
| Pfizer INC. | $76.64 | 2025 | |
| Lilly USA, LLC | $70.61 | 2024-2025 | Zepbound, Jardiance, Mounjaro |
| Glaxosmithkline, LLC. | $58.95 | 2025 | Shingrix, Arexvy |
| Exact Sciences Corporation | $51.30 | 2025 | Cologuard Collection Kit |
| Abbvie INC. | $43.75 | 2025 | |
| Merck Sharp & Dohme LLC | $35.15 | 2020-2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kissa Walker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.